Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer

NCT06342414 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT06342414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06342414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Recruiting
Start date
March 15, 2024
Completion date
June 18, 2028
Enrollment
400 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, hepatic cancer, hepatic carcinoma, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, primary liver cancer, primary liver carcinoma